Attached files
| file | filename |
|---|---|
| 10-K - FORM 10-K - XBiotech Inc. | f10k_031620p.htm |
| EX-32.2 - EXHIBIT 32.2 - XBiotech Inc. | exh_322.htm |
| EX-31.2 - EXHIBIT 31.2 - XBiotech Inc. | exh_312.htm |
| EX-31.1 - EXHIBIT 31.1 - XBiotech Inc. | exh_311.htm |
| EX-23.1 - EXHIBIT 23.1 - XBiotech Inc. | exh_231.htm |
| EX-21.1 - EXHIBIT 21.1 - XBiotech Inc. | exh_211.htm |
| EX-10.15 - EXHIBIT 10.15 - XBiotech Inc. | exh_1015.htm |
| EX-10.14 - EXHIBIT 10.14 - XBiotech Inc. | exh_1014.htm |
| EX-4.1 - EXHIBIT 4.1 - XBiotech Inc. | exh_41.htm |
Exhibit 32.1
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT
TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report of XBiotech Inc. on Form 10-K for the period ended December 31, 2019 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, John Simard, Chief Executive Officer and President of the Company, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:
(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of XBiotech Inc.
| /S/ JOHN SIMARD | ||
| John Simard | ||
| Chief Executive Officer and President | ||
| (Principal Executive Officer) | ||
| Date: March 16, 2020 |